Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Aoxing Pharmaceutical Group
Shijiazhuang, Hebei Province, Chinaen.aoxin-group.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Hebei Aoxing Pharmaceutical Group is a specialty pharmaceutical company focused on narcotics and pain management products. The company has the largest manufacturing facility and product pipeline for highly regulated narcotic medicines in China, with multiple drugs approved for commercial distribution and several in clinical development.[4][6][10]
- Therapeutic areas
- OtherCardiovascularNeurologyInfectious DiseasesGastroenterology
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
Johnson Matthey Plc (joint venture for API production)Macfarlan Smith Ltd. (subsidiary of Johnson Matthey)QRxPharmaPhoenix PharmaLabs, Inc.American Oriental Bioengineering, Inc.
Beyond the preview
Go deeper on Hebei Aoxing Pharmaceutical Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hebei Aoxing Pharmaceutical Group.